Osimertinib Impurity 19
| CAT. No. | CP-O17045 |
|---|---|
| CAS. No. | 394-18-3 |
| Mol. F. | C7H5FN2O5 |
| Mol. Wt. | 216.12 |
| Stock Status | Custom Synthesis |
- Category: Impurity Standards
- Synonyms: NA
- Chemical Name: Benzene, 1-fluoro-5-methoxy-2,4-dinitro
Request for Quotation : Osimertinib Impurity 19
Related Products
| CAT. No. | CP-O17000 |
|---|---|
| CAS. No. | 1421373-65-0 |
| Mol. F. | C28H33N7O2 |
| Mol. Wt. | 499.62 |
| Stock Status: | In Stock |
| CAT. No. | CP-O17001 |
|---|---|
| CAS. No. | 1421373-98-9 |
| Mol. F. | C27H31N7O2 |
| Mol. Wt. | 485.59 |
| Stock Status: | Custom Synthesis |
| CAT. No. | CP-O17002 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C28H32N8O3 |
| Mol. Wt. | 528.62 |
| Stock Status: | Please Enquire |
| CAT. No. | CP-O17003 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C27H30N8O3 |
| Mol. Wt. | 514.59 |
| Stock Status: | Please Enquire |
| CAT. No. | CP-O17004 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C27H30N8O3 |
| Mol. Wt. | 514.59 |
| Stock Status: | Custom Synthesis |
| CAT. No. | CP-O17005 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C27H30N8O3 |
| Mol. Wt. | 514.59 |
| Stock Status: | Custom Synthesis |
| CAT. No. | CP-O17009 |
|---|---|
| CAS. No. | 1421373-66-1 |
| Mol. F. | C28H33N7O2 : CH4O3S |
| Mol. Wt. | 499.62 : 96.10 |
| Stock Status: | In Stock |
| CAT. No. | CP-O17006 |
|---|---|
| CAS. No. | 1421372-66-8 |
| Mol. F. | C25H31N7O |
| Mol. Wt. | 445.57 |
| Stock Status: | In Stock |
| CAT. No. | CP-O17007 |
|---|---|
| CAS. No. | 2850389-35-2 |
| Mol. F. | C30H33N7O3 |
| Mol. Wt. | 539.64 |
| Stock Status: | Custom Synthesis |
| CAT. No. | CP-O17008 |
|---|---|
| CAS. No. | 3050754-62-3 |
| Mol. F. | C29H37N7O3 |
| Mol. Wt. | 531.66 |
| Stock Status: | In Stock |
| CAT. No. | CP-O17010 |
|---|---|
| CAS. No. | 2044702-39-6 |
| Mol. F. | C25H26N6O2 |
| Mol. Wt. | 442.52 |
| Stock Status: | Custom Synthesis |
| CAT. No. | CP-O17011 |
|---|---|
| CAS. No. | 2044702-55-6 |
| Mol. F. | C22H24N6O : HCl |
| Mol. Wt. | 388.48 : 36.5 |
| Stock Status: | Custom Synthesis |
